Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ProPhase Labs Inc - SIC # 8071 - MEDICAL LABORATORIES
Ticker
Exchange
SIC #
Website
Latest Ticker
PRPH
Nasdaq
8071
https://www.prophaselabs.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ProPhase Labs Inc
ProPhase Labs, Inc. (PRPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- May 2nd, 2024 2:01 pm
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
- May 2nd, 2024 12:00 pm
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
- Apr 29th, 2024 1:00 pm
ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
- Apr 25th, 2024 12:00 pm
Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)
- Apr 23rd, 2024 1:00 pm
ProPhase Labs Unveils Project ZenQ-AI
- Apr 16th, 2024 12:00 pm
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
- Apr 15th, 2024 11:47 am
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024
- Apr 10th, 2024 12:00 pm
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Apr 2nd, 2024 1:00 am
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
- Mar 18th, 2024 1:20 pm
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives
- Mar 15th, 2024 12:00 pm
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024
- Mar 8th, 2024 1:00 pm
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 29% Above Their Intrinsic Value Estimate
- Mar 1st, 2024 11:28 am
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test DevelopmentĀ USPTO grants additional broad patents for BE-SMART
- Feb 20th, 2024 1:00 pm
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir
- Feb 14th, 2024 1:00 pm
Diamond Equity Research Releases In Depth Update Note on ProPhase Labs, Inc. (NASDAQ: PRPH) subsidiary, Pharmaloz Manufacturing, Inc. (PMI)
- Feb 8th, 2024 1:00 pm
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics
- Jan 30th, 2024 1:00 pm
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts
- Jan 23rd, 2024 1:00 pm
ProPhase poised to ramp up growth at Pharmaloz and Nebula Genomics in 2024
- Jan 4th, 2024 1:00 pm
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript
- Nov 10th, 2023 6:50 pm
Scroll